Reconsidering False Positive Rates for a Portfolio of Carcinogenicity Studies

Laura Betz Co-Author
DLH
 
Shawn Harris Co-Author
DLH
 
Katherine Allen Co-Author
DLH
 
Helen Cunny Co-Author
Division of Translational Toxicology, NIEHS
 
Keith Shockley Co-Author
National Institute of Health
 
Kathryn Konrad First Author
DLH
 
Kathryn Konrad Presenting Author
DLH
 
Monday, Aug 4: 9:45 AM - 9:50 AM
1786 
Contributed Speed 
Music City Center 
Hundreds of chemicals have been evaluated for their potential carcinogenicity via two-year rodent studies. Each study includes two rodent species, two sexes, three or more dose groups, and over 40 tumor types. The data are binary, with tumors being either present or not. With over 480 dose-related trend and pairwise tests per study, there are concerns about the overall false positive rate (FPR). While statistical significance is not the only consideration for declaring the carcinogenicity of a chemical, it is an important contributing factor. Previous work has examined FPRs, but the data and methods have changed over time: tumor background rates have shifted, and more sophisticated models are sometimes needed. Newer methods include adjustments for differential survivability among the dose groups. Here, we use simulations to assess a study's FPR using the Poly-3 test. These simulations use current historical controls data and assist in estimating the FPR of a study. This work seeks to emphasize the real-world impact of statistical modeling and enhance confidence in science. This research was supported in part by the Intramural Research Program of the NIH including 75N96022F00055.

Keywords

False Positive Rate

Simulation

Carcinogenicity

Binary Data 

Main Sponsor

Health Policy Statistics Section